Table 3:
Neurodevelopmental outcome: separated into groups by postmenstrual age at scanninga
| 27–29 Weeks (n = 22) (Median) (IQR) | 30–33 Weeks (n = 93) (Median) (IQR) | 34–36 Weeks (n = 32) (Median) (IQR) | 37–41 Weeks (n = 94) (Median) (IQR) | |
|---|---|---|---|---|
| Age at follow-up (mo)b | 18.7 (18.4–19.2) | 18.7 (18.3–19.7) | 18.6 (18.3–19.1) | 18.8 (18.4–19.4) |
| Bayley-III cognitivec | 105 (100–110) | 110 (100–115) | 102.5 (92.5–110) | 105 (95–110) |
| Bayley-III languagec | 101.5 (83.5–111.3) | 100 (91–109) | 95.5 (83–109) | 100 (86.8–108.3) |
| Bayley-III motorc | 98.5 (88.8–105.3) | 100 (91.8–107) | 92.5 (84.3–104) | 97 (88–107) |
| PDMS-2 Gross Motorc | 91 (87–96) | 94 (87–98) | 89 (79–96) | 91 (87–98) |
| PDMS-2 Fine Motorc | 100 (97–106) | 100 (97–103) | 97 (89.5–103) | 100 (94–103) |
| PDMS-2 Total Motorc | 96 (90–101) | 96 (92–98) | 92 (84–97) | 94 (89–98) |
a
One hundred sixty-six neonates returned for neurodevelopmental follow-up. DTI data were acquired in 75 of the neonates early and in 75 of the neonates at early and late time points (150 scans). Sixteen neonates had late scans for a total of 241 scans.
b
Age corrected for prematurity.
c
The mean composite score in a normative population is 100 ± 15.